Literature DB >> 28822154

[A new benzamide derivative from rice fermentation of Streptomyces sp. CPCC 202950].

Shan-Shan Chang1,2, Ming-Hua Chen2, Ren-Zhong Wang2, Ye-Xiang Wu2, Guo-Hong Yang2, Biao Dong2, Li-Yan Yu2, Zeng-Ping Gao1, Shu-Yi Si2.   

Abstract

Eight compounds were isolated from the rice fermentation of Streptomyces sp. CPCC 202950 by a combination of various chromatographic techniques including column chromatography over silica, Sephadex LH-20, flash C₁₈, and reversed-phase HPLC. Their structures were identified as 3-[(3'-amino-3'-oxoprop-1'-en-2'-yl)oxy]benzamide (1), m-hydroxybenzamide (2), leptosphaepin (3), 5-methyluracil (4), feruloylamide (5), p-hydroxyphenylacetoamide (6), vanillamide (7), cyclo (L-val-L-ala) (8). Among them, 1 was a new benzamide analogue, and 2 was a new natural product. In the preliminary assays, none of the compounds 1-8 exhibited obvious inhibition of HIV-1 protease activity, and toxic with the Hela, HepG2, and U2OS cells. (IC₅₀ > 10 μmol•L⁻¹). Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  HIV-1 protease inhibitor ; Streptomyces sp. CPCC 202950 ; chemical constituents ; rice fermentation ; benzamide

Mesh:

Substances:

Year:  2017        PMID: 28822154     DOI: 10.19540/j.cnki.cjcmm.2017.0093

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  1 in total

1.  Ahmpatinin iBu, a new HIV-1 protease inhibitor, from Streptomyces sp. CPCC 202950.

Authors:  Ming-Hua Chen; Shan-Shan Chang; Biao Dong; Li-Yan Yu; Ye-Xiang Wu; Ren-Zhong Wang; Wei Jiang; Zeng-Ping Gao; Shu-Yi Si
Journal:  RSC Adv       Date:  2018-01-30       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.